Skip to content

Swallowing problems - Influence of the shape of solid oral dosage forms on dysphagic patients' swallowability

Swallowing problems - Influence of the shape of solid oral dosage forms on dysphagic patients' swallowability - K306

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003218
Enrollment
50
Registered
2011-08-31
Start date
2011-09-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R13.9

Interventions

Group 1: Dysphagia screening of all stroke and Parkinson's disease patients of a geriatric hospital. Patients who potentially suffer from dysphagia can take part in a videoendoscopic evaluation of swa

Sponsors

Universitätsklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult 2. Stroke and Parkinson's disease patients 3. Long-term therapy with at least one solid oral drug 4. Patients with positiv Daniels-test or suspicion of dysphagia when being assessed by a speech therapist, which indicates a videoendoscopic evaluation of swallowing 5. Inpatient in the Bethanien Hospital

Exclusion criteria

Exclusion criteria: 1. Patients who are not able to follow easy instructions 2. Patients who cannot be positioned upright 3. Medium and severe dementia 4. Somnolent patients or patients with delirium 5. Patients with a negativ Daniels-test and no dysphagia symptoms when being assessed by a speech therapist 6. Non-stroke and non-Parkinson's disease patients

Design outcomes

Primary

MeasureTime frame
1. Prevalence of dysphagic patients who are able to swallow solid oral dosage forms 2. Ideal solid dosage form for patients with dysphagia

Secondary

MeasureTime frame
1. Differentiated evaluation of the swallowability of solid dosage forms 2. Frequency of drug modifications for dysphagic patients 3. Frequency of inadequate drug modifications for dysphagic patients 4. Frequency of drug modifications for dysphagic patients, who would be able to swallow drugs without modifications (based on the results of the videoendoscopy) 5. Frequency of possible dosage form substitutions, which could facilitate swallowing of drugs for dysphagic patients

Countries

Germany

Contacts

Public ContactHeike;Julia Penner;Schiele

Agaplesion Bethanien Krankenhaus ;Universitätsklinikum Heidelberg

hpenner@bethanien-heidelberg.de;julia.schiele@med.uni-heidelberg.de06221/319-1542;06221/56-37113

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026